Related Experiment Video
Updated: Jan 7, 2026

07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
37.1K
Biomarkers
Larissa Fischer1,2, Jenna N Adams2, Eóin N Molloy1,3
1German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
Summary
Functional connectivity (FC) changes in medial temporal lobe (MTL) and posteromedial cortex (PMC) are linked to Alzheimer's pathology and memory decline, especially in APOE4 carriers. Network changes differ between rest and task states.
Area of Science:
- Neuroscience
- Cognitive Science
- Medical Imaging
Background:
- The medial temporal lobe (MTL) and posteromedial cortex (PMC) are crucial for episodic memory and are early sites of Alzheimer's disease (AD) pathology.
- APOE4 genotype is a significant risk factor for AD, influencing pathology accumulation and cognitive decline.
- Functional connectivity (FC) alterations within and between MTL and PMC may reflect compensatory or detrimental neural network changes in AD pathogenesis.
Purpose of the Study:
- To investigate the relationship between longitudinal changes in functional connectivity (FC) within and between the MTL and PMC and Alzheimer's pathology burden.
- To examine how these FC changes relate to cognitive performance, specifically delayed memory recall and object recognition.
- To explore the moderating role of the APOE genotype in these associations.
Main Methods:
- Longitudinal 3-Tesla fMRI data and cross-sectional amyloid-beta and tau PET imaging were analyzed from the PREVENT-AD cohort.
- Changes in resting-state FC (RSFC) and task-based FC during object-location encoding were assessed within (ΔFCPMC, ΔFCMTL) and between (ΔFCMTL-PMC) these regions.
- Multiple regression and linear mixed models were used to investigate associations between ΔFC, pathology, memory changes, and APOE genotype in 152 cognitively unimpaired older adults.
Main Results:
- APOE genotype modulated the association between FC changes and pathology: declining RSFCPMC correlated with higher amyloid in APOE4 carriers, while increasing encoding-FCMTL correlated with higher tau in APOE4 carriers.
- Increased encoding-FCPMC was associated with poorer memory performance (RBANS and object recognition) irrespective of APOE status.
- Increased RSFCMTL-PMC was linked to improved RBANS performance, whereas increased encoding-FCMTL-PMC was linked to decreased object recognition.
Conclusions:
- Longitudinal FC changes within and between MTL and PMC show APOE-dependent associations with AD pathology and memory performance.
- Network alterations manifest differently during rest versus task conditions, highlighting the importance of dynamic FC assessments.
- In APOE4 carriers, increased MTL connectivity during encoding relates to tau pathology, while decreased PMC connectivity during rest relates to amyloid, suggesting distinct pathological mechanisms in these regions.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

